MétaCan
Menu
Back to cohort
Record W4366448631 · doi:10.1038/s41416-023-02263-5

Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

2023· article· en· W4366448631 on OpenAlexafffund
Denise G O'Mahony, Susan J. Ramus, Melissa C. Southey, Nicola S. Meagher, Andreas Hadjisavvas, Esther M. John, Ute Hamann, Evgeny N. Imyanitov, Irene L. Andrulis, Priyanka Sharma, Mary B. Daly, Christopher R. Hake, Jeffrey N. Weitzel, Anna Jakubowska, Andrew K. Godwin, Aðalgeir Arason, Anita Bane, Jacques Simard, Penny Soucy, Maria A. Caligo, Kathleen Claes, Manuel R. Teixeira, Wendy K. Chung, Conxi Lázaro, Peter J. Hulick, Amanda E. Toland, Inge Søkilde Pedersen, Marian J.E. Mourits, Susan L. Neuhausen, Ana Vega, Miguel de la Hoya, Heli Nevanlinna, Mallika Dhawan, Valentina Zampiga, Rita Danesi, Liliana Varesco, Viviana Gismondi, Valerio Gaetano Vellone, Paul A. James, Ramūnas Janavičius, Liene Ņikitina-Zaķe, Finn Cilius Nielsen, Thomas van Overeem Hansen, Tanja Pejović, Åke Borg, Johanna Rantala, Kenneth Offit, Marco Montagna, Katherine L. Nathanson, Susan M. Domchek, Ana Osório, María J. García, Beth Y. Karlan, Fabienne Lesueur, Anna de Fazio, David D.L. Bowtell, Lesley McGuffog, Goska Leslie, Michael T. Parsons, Thilo Dörk, Lisa‐Marie Speith, Elizabeth Santana Dos Santos, Alexandre André Balieiro Anastácio da Costa, Paolo Radice, Paolo Peterlongo, Laura Papi, Christoph Engel, Eric Hahnen, Rita K. Schmutzler, Barbara Wappenschmidt, Douglas F. Easton, Marc Tischkowitz, Christian F. Singer, Yen Y. Tan, Alice S. Whittemore, Weiva Sieh, James D. Brenton, Drakoulis Yannoukakos, Florentia Fostira, Irene Konstantopoulou, Jana Soukupová, Michal Vočka, Georgia Chenevix‐Trench, Paul D.P. Pharoah, Antonis C. Antoniou, David E. Goldgar, Amanda B. Spurdle, Kyriaki Michailidou

Bibliographic record

VenueBritish Journal of Cancer · 2023
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsMcGill UniversityUniversité LavalCentre hospitalier universitaire de QuébecMount Sinai HospitalLunenfeld-Tanenbaum Research InstituteJuravinski HospitalMcMaster UniversityUniversity of Toronto
FundersMedical Research and Materiel CommandEuropean Social FundNational Center for Advancing Translational SciencesEuropean Regional Development FundInstituto de Salud Carlos IIICancer Council TasmaniaCancer Council NSWCancer Council VictoriaMedical Research CouncilCanadian Institutes of Health ResearchCancer Center, University of KansasNational Institutes of HealthGovernment of CanadaCentre Léon BérardNIH Office of the DirectorMaastricht Universitair Medisch CentrumUniversiteit LeidenInstitut Claudius RegaudDeutsches KrebsforschungszentrumUnicancerFreistaat SachsenFox Chase Cancer CenterMinistero dello Sviluppo EconomicoHospices Civils de LyonCancer Council South AustraliaInstitut BergoniéDeutsche KrebshilfeNational Institute of General Medical SciencesLeids Universitair Medisch CentrumNederlandse Organisatie voor Wetenschappelijk OnderzoekInstitut Gustave-RoussyErasmus Medisch CentrumRadboud Universitair Medisch CentrumGeneralitat de CatalunyaOvarian Cancer Research FundBundesministerium für Bildung und ForschungUniversiteit MaastrichtFundación Mutua MadrileñaMinistère du Développement Économique, de l’Innovation et de l’ExportationRadboud UniversiteitNational Cancer InstitutePeter MacCallum FoundationInstitut National de la Santé et de la Recherche MédicaleCancer Research UKFondation du cancer du sein du QuébecGray FoundationRoyal Marsden NHS Foundation TrustCentres de Recerca de CatalunyaOvarian Cancer AustraliaAssociazione Italiana per la Ricerca sul CancroGenome CanadaBreast Cancer Research FoundationUniverzita Karlova v PrazeNational Institute for Health and Care ResearchKansas Bioscience AuthorityAmsterdam University Medical CentersRijksuniversiteit GroningenCancer AustraliaMinisterstvo Zdravotnictví Ceské RepublikyEuropean CommissionLietuvos Mokslo TarybaNational Health and Medical Research CouncilFundación CellexUniversitair Medisch Centrum Groningen
KeywordsCancerOvarian cancerPathogenicityPathologyMedicineBiologyOncologyInternal medicine

Abstract

fetched live from OpenAlex

BACKGROUND: The distribution of ovarian tumour characteristics differs between germline BRCA1 and BRCA2 pathogenic variant carriers and non-carriers. In this study, we assessed the utility of ovarian tumour characteristics as predictors of BRCA1 and BRCA2 variant pathogenicity, for application using the American College of Medical Genetics and the Association for Molecular Pathology (ACMG/AMP) variant classification system. METHODS: Data for 10,373 ovarian cancer cases, including carriers and non-carriers of BRCA1 or BRCA2 pathogenic variants, were collected from unpublished international cohorts and consortia and published studies. Likelihood ratios (LR) were calculated for the association of ovarian cancer histology and other characteristics, with BRCA1 and BRCA2 variant pathogenicity. Estimates were aligned to ACMG/AMP code strengths (supporting, moderate, strong). RESULTS: No histological subtype provided informative ACMG/AMP evidence in favour of BRCA1 and BRCA2 variant pathogenicity. Evidence against variant pathogenicity was estimated for the mucinous and clear cell histologies (supporting) and borderline cases (moderate). Refined associations are provided according to tumour grade, invasion and age at diagnosis. CONCLUSIONS: We provide detailed estimates for predicting BRCA1 and BRCA2 variant pathogenicity based on ovarian tumour characteristics. This evidence can be combined with other variant information under the ACMG/AMP classification system, to improve classification and carrier clinical management.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.017
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.021

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.017
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0020.002
Science and technology studies0.0000.001
Scholarly communication0.0010.000
Open science0.0000.001
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.009
GPT teacher head0.273
Teacher spread0.264 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations19
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueBritish Journal of CancerSame topicBRCA gene mutations in cancerFrench-language works237,207